Surgalign Holdings announces the release of HOLO AI Insights. HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s HOLO artificial intelligence portfolio through a secure, highly scalable cloud platform for automated analysis of medical images. HOLO AI, Surgalign’s portfolio of AI technology, utilizes convolutional neural network technology to automate various tasks such as segmenting medical images, measuring anatomic structures, and planning pedicle screw placement. As part of Surgalign’s HOLO AI portfolio, HOLO AI Insights analyzes standard protocol lumbar spine MRI images, providing quantitative measurements of 16 different anatomic structures in the spine. Currently, this image processing is being utilized for retrospective data analysis of patient specific medical information from participating sites. The insights generated have the potential for multiple applications in population health, clinical research, and in the future, patient care.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SRGA:
- Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging
- Surgalign sees 2022 revenue $82M, cash balance $16.3M
- Surgalign on track to achieve target cash savings of $30M-$35M in 2023
- Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance
- Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas
